On 15 March 2017, the ACS PharmaProtect GmbH Berlin, the German Medicines Manufacturers' Association (Bundesverband der Arzneimittelhersteller e.V., Berlin - BAH), the German Pharmaceutical Industry Association (Bundesverband der Pharmazeutischen Industrie e.V., Berlin - BPI), the ProGenerika e.V.Berlin together with the Association of Research-Based Pharmaceutical Companies (Verband Forschender Arzneimittelhersteller e.V., Berlin - vfa) published a common press release announcing the joining of Pro Generika e.V. as the fourth shareholder in the ACS PharmProtect GmbH.
2017年3月15日，ACS PharmaProtect柏林公司、德国药品生产商协会（BAH）、德国药品行业协会（BPI）、ProGenerika e.V柏林与药品研发公司协会（VFA）共同发布了一份新闻宣布加入Pro Generika e.V.成为ACS PharmProtect德国公司的第4大股东。
ACS was founded in 2012 with the aim of developing and operating the manufacturer database in Germany.
ACS成立于2012年，其目的是在德国建立和运营生产商数据库。
Indeed, the manufacturer database is a significant part of the securPharm initiative in Germany.
实际上，生产商数据库是securPharm在德国的活动的重要部分。
The joining of Pro Generika e.V. shows that now the entire pharmaceutical industry in Germany pushes the prevention of the entry of falsified medicines into the legal supply chain.
Pro Generika e.V.的加入表明目前德国的整个医药行业正在推进防止假药进入合法供应链的工作。
The future safety features required for the implementation of the Anti-Counterfeiting Directive have to be implemented as of 9th February 2019. Moreover, the national verification systems will have to be available. From that date, medicinal products will have to be checked for their authenticity before dispensing to patients. The data required for that have to be stored by the manufacturer of the medicinal product in the database provided by ACS.
未来在2019年2月9日必须要实施防伪指令所需的安全措施。另外，还需要建立全国认证系统。自上述日期起，药品在分发给患者之前必须验证其真伪。验证所需的数据则必须由药品生产商存贮在ACS所提供的数据库中。
For further information please see the complete press release "Pro Generika e.V. becomes shareholder of the industry's database system in the securPharm-system".
更多信息，参见完整的新闻发布稿。| 欢迎光临 药群论坛 (http://www.yaoqun.net/) | Powered by Discuz! X3.2 |